Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AbbVie
Biotech
AbbVie Parkinson's drug from $8.7B Cerevel buyout scores
The drug, tavapadon, also hit a secondary endpoint of improving the mobility of patients in their daily lives.
Darren Incorvaia
Sep 26, 2024 10:45am
AbbVie sues BeiGene over blood cancer drug trade secrets
Sep 11, 2024 10:17am
Aldeyra preps for FDA refiling as dry eye drug hits ph. 3 goal
Aug 8, 2024 10:48am
AbbVie axes Alzheimer's program amid 'evolving landscape'
Jul 25, 2024 10:49am
Sionna salvages AbbVie assets for assault on cystic fibrosis
Jul 16, 2024 10:00am
AbbVie turns up the M&A heat with $250M Celsius buy
Jun 27, 2024 11:00am